Ghana malaria drug resistance warning system that uses maps and genomics
Official title: Geo-enabled detect and respond system for antimalarial resistance in Ghana: GDRS - Ghana
Funded at Institute of Human Virology · NIH-11550783 · Data updated 2026-11-12
A U01 grant is building a geospatial and genomic monitoring system to detect emerging antimalarial drug resistance in West Africa, with collaboration between Akros and WACCBIP/IHV-N.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute of Human Virology NIH-funded |
| Lab location | 1 site (Abuja, Nigeria) |
| Project start | February 23, 2024 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $50,023 |
| NIH project number | 3U01TW012531-04S2 |
| Project ID | NIH-11550783 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are communities in West Africa where antimalarial resistance is being monitored and where surveillance activities may occur.
✕Less likely to help
People in regions without malaria or where surveillance is not conducted may not directly benefit.
What this research studies
This project creates an integrated system that combines genomic data, epidemiology, and geospatial information to spot early signals of antimalarial drug resistance in West Africa. Researchers will collect and analyze samples and data from affected areas, and connect findings to real-time public health actions. The effort is designed to strengthen outbreak preparedness and guide timely responses to resistance patterns and outbreaks. The collaboration spans multiple institutions across Africa and joins local and international expertise to improve malaria control.
Why it matters
Potential benefit: If successful, this system could lead to faster detection of drug resistance and more effective public health responses to protect people from malaria.
How similar studies have gone: Genomic and geospatial surveillance approaches have shown promise in detecting resistance and guiding responses in similar settings.
Where this research is happening
-
Institute of Human Virology
Abuja, Nigeria Active
Researchers
- Principal investigator: Abimiku, Alash'le G. — Institute of Human Virology
- Study coordinator: Abimiku, Alash'le G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.